Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • skoddo
    Junior Member
    • Jul 2012
    • 3

    #1

    DESeq: Normalisation of library sizes with physiological meaning

    I have a question concerning the data normalisation used in DESeq. While I do understand the need of normalisation of differences in library sizes that originate from the library preparation, I have problems normalizing the differences that originate from the biological variance of my samples.

    Hopefully the following example can make my point come across:

    RNA Samples 1 and 2 are extracted from different tissues/treatments. Library prep was performed for Small RNAs with the same amount of RNA and resulting reads were mapped on the whole genome and annotated with their corresponding mirbase.
    Now lets assume Sample 1 has 20 Mio Reads and Sample 2 has 17 Mio Reads after sequencing. After annotation however I end up with 8 Mio reads for Sample 1 and 16 Mio reads for Sample 2 that represent the miRNAs in them.

    If I follow the normal DESeq procedure, it will normalize my read counts concerning the 8 and 16 mio library sizes respectively. While this gives me the differences if I would look at the same amount of miRNA in both samples, it does not reflect the differences that were really caused by the treatment. For instance if I plot the insert sizes after adapter trimming I can see a significant shift between these two samples caused by the treatment.

    I thought about adding a virtual gene to each sample which would account for the starting library sizes. So in my example for sample 1 that would add 12 mio reads and for sample 2 only 1 mio reads. But I'm not sure how that would alter the variance estimation of DESeq.

    Any help would be appreciated.
    Regards
    Benedikt

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...